Therapeutic Solutions International Expands Adoptive Immunotherapy Portfolio by Incorporation of "Universal Cancer Antigen" into StemVacs Dendritic Cell Platform
11 juin 2018 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire --Therapeutics Solutions International, Inc., (OTC Markets:TSOI) announced today initiation of efforts to combine its existing...
Therapeutic Solutions International to Provide Patients Access to StemVacs Cancer Immunotherapy through Newly Passed Right to Try Law
31 mai 2018 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., May 31, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Therapeutics Solutions International, Inc., (OTC Markets:TSOI) announced today their plans to provide access to its clinical...
Therapeutic Solutions International Launches Multi-Protocol Cancer Immunotherapy Clinical Trial with Pan Am Cancer Treatment Centers
01 mai 2018 09h00 HE
|
Therapeutic Solutions International, Inc.
Company Aims to Leverage Transfer Factor Pulsed Autologous Dendritic Cells on StemVacs Platform withPatented Augmenter of Cancer Immunotherapy NanoStilbene OCEANSIDE, Calif., May 01, 2018 ...